BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 17400922)

  • 1. Crystal structure of the human ephrin-A5 ectodomain.
    Nikolov D; Li C; Lackmann M; Jeffrey P; Himanen J
    Protein Sci; 2007 May; 16(5):996-1000. PubMed ID: 17400922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of the ephrin-B1 ectodomain: implications for receptor recognition and signaling.
    Nikolov DB; Li C; Barton WA; Himanen JP
    Biochemistry; 2005 Aug; 44(33):10947-53. PubMed ID: 16101278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinctive Structure of the EphA3/Ephrin-A5 Complex Reveals a Dual Mode of Eph Receptor Interaction for Ephrin-A5.
    Forse GJ; Uson ML; Nasertorabi F; Kolatkar A; Lamberto I; Pasquale EB; Kuhn P
    PLoS One; 2015; 10(5):e0127081. PubMed ID: 25993310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repelling class discrimination: ephrin-A5 binds to and activates EphB2 receptor signaling.
    Himanen JP; Chumley MJ; Lackmann M; Li C; Barton WA; Jeffrey PD; Vearing C; Geleick D; Feldheim DA; Boyd AW; Henkemeyer M; Nikolov DB
    Nat Neurosci; 2004 May; 7(5):501-9. PubMed ID: 15107857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of the ligand-binding domain of the receptor tyrosine kinase EphB2.
    Himanen JP; Henkemeyer M; Nikolov DB
    Nature; 1998 Dec; 396(6710):486-91. PubMed ID: 9853759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into Eph receptor tyrosine kinase activation from crystal structures of the EphA4 ectodomain and its complex with ephrin-A5.
    Xu K; Tzvetkova-Robev D; Xu Y; Goldgur Y; Chan YP; Himanen JP; Nikolov DB
    Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14634-9. PubMed ID: 23959867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three distinct molecular surfaces in ephrin-A5 are essential for a functional interaction with EphA3.
    Day B; To C; Himanen JP; Smith FM; Nikolov DB; Boyd AW; Lackmann M
    J Biol Chem; 2005 Jul; 280(28):26526-32. PubMed ID: 15901737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of an Eph receptor-ephrin complex.
    Himanen JP; Rajashankar KR; Lackmann M; Cowan CA; Henkemeyer M; Nikolov DB
    Nature; 2001 Dec 20-27; 414(6866):933-8. PubMed ID: 11780069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissecting the EphA3/Ephrin-A5 interactions using a novel functional mutagenesis screen.
    Smith FM; Vearing C; Lackmann M; Treutlein H; Himanen J; Chen K; Saul A; Nikolov D; Boyd AW
    J Biol Chem; 2004 Mar; 279(10):9522-31. PubMed ID: 14660665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMR structure and dynamics of human ephrin-B2 ectodomain: the functionally critical C-D and G-H loops are highly dynamic in solution.
    Ran X; Qin H; Liu J; Fan JS; Shi J; Song J
    Proteins; 2008 Aug; 72(3):1019-29. PubMed ID: 18300229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adam meets Eph: an ADAM substrate recognition module acts as a molecular switch for ephrin cleavage in trans.
    Janes PW; Saha N; Barton WA; Kolev MV; Wimmer-Kleikamp SH; Nievergall E; Blobel CP; Himanen JP; Lackmann M; Nikolov DB
    Cell; 2005 Oct; 123(2):291-304. PubMed ID: 16239146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of the ligand-binding domain of the EphB2 receptor at 2 A resolution.
    Goldgur Y; Paavilainen S; Nikolov D; Himanen JP
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2009 Feb; 65(Pt 2):71-4. PubMed ID: 19193989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Architecture of Eph receptor clusters.
    Himanen JP; Yermekbayeva L; Janes PW; Walker JR; Xu K; Atapattu L; Rajashankar KR; Mensinga A; Lackmann M; Nikolov DB; Dhe-Paganon S
    Proc Natl Acad Sci U S A; 2010 Jun; 107(24):10860-5. PubMed ID: 20505120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent binding of anti-EphA3 antibody and ephrin-A5 amplifies EphA3 signaling and downstream responses: potential as EphA3-specific tumor-targeting reagents.
    Vearing C; Lee FT; Wimmer-Kleikamp S; Spirkoska V; To C; Stylianou C; Spanevello M; Brechbiel M; Boyd AW; Scott AM; Lackmann M
    Cancer Res; 2005 Aug; 65(15):6745-54. PubMed ID: 16061656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification, crystallization and preliminary characterization of an Eph-B2/ephrin-B2 complex.
    Himanen JP; Nikolov DB
    Acta Crystallogr D Biol Crystallogr; 2002 Mar; 58(Pt 3):533-5. PubMed ID: 11856847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure of an ephrin ectodomain.
    Toth J; Cutforth T; Gelinas AD; Bethoney KA; Bard J; Harrison CJ
    Dev Cell; 2001 Jul; 1(1):83-92. PubMed ID: 11703926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ectodomain structures of Eph receptors.
    Himanen JP
    Semin Cell Dev Biol; 2012 Feb; 23(1):35-42. PubMed ID: 22044883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ephrins stimulate neurite outgrowth during early cortical neurogenesis.
    Zhou X; Suh J; Cerretti DP; Zhou R; DiCicco-Bloom E
    J Neurosci Res; 2001 Dec; 66(6):1054-63. PubMed ID: 11746437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADAM and Eph: how Ephrin-signaling cells become detached.
    Mancia F; Shapiro L
    Cell; 2005 Oct; 123(2):185-7. PubMed ID: 16239135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ephrin-A5 induces rounding, blebbing and de-adhesion of EphA3-expressing 293T and melanoma cells by CrkII and Rho-mediated signalling.
    Lawrenson ID; Wimmer-Kleikamp SH; Lock P; Schoenwaelder SM; Down M; Boyd AW; Alewood PF; Lackmann M
    J Cell Sci; 2002 Mar; 115(Pt 5):1059-72. PubMed ID: 11870224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.